PREMIUM
ONCOLOGY
APPROVALS
COVALENTS
5 minute read
Jan. 10, 2023

The First Approved Covalent pan-FGFR1-4 Kinase Inhibitor, Futibatinib

drughunter.com
Drug Hunter Team
Loading...
twitterlinkedinemail

Other articles you may be interested in